jili super ace free 100
Blackstone: My No. 1 Investment Of All-TimeClinical and regulatory success in 2024 expected to drive value in 2025 CRANFORD, N.J. , Dec. 27, 2024 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR), a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products today reported business and financial results for the fiscal full year ended September 30, 2024 . Fiscal Full Year 2024 Business Highlights and Subsequent Developments Financial Highlights "In fiscal year 2024 we drove tremendous progress in our pipeline. It was a transformative year, marked by our first FDA approval and significant clinical milestones. The approval of LYMPHIRTM and the positive Phase 3 results for Mino-Lok® underscore our commitment to developing innovative therapies. Our team successfully responded to FDA comments related to the biologics license application for LYMPHIR and ultimately gained FDA approval. Productive engagement with the FDA regarding the positive results of our Phase 3 Mino-Lok® trial and Phase 2 Halo-Lido trial clarified our next steps for both programs. We anticipate continued engagement with the agency in the coming year and look forward to their guidance. Additionally, we are exploring strategic partnerships and licensing opportunities to maximize the potential of our portfolio and bring these important therapies to market efficiently," stated Leonard Mazur , Chairman and CEO of Citius Pharma. "Looking ahead, our priorities for fiscal year 2025 include launching LYMPHIRTM through our majority-owned subsidiary, Citius Oncology, driving the clinical and regulatory strategies for Mino-Lok® and Halo-Lido, fortifying our financial position, and applying a disciplined approach to resource allocation. We expect to launch LYMPHIR in the first half of 2025 and distribute CTOR shares to Citius Pharma shareholders by the end of the year, pending favorable market conditions. Our goal remains to deliver value for patients, healthcare providers, and shareholders. With a clear vision and a strong team, we are well-positioned to execute on our mission of bringing innovative therapies to market," added Mazur. FULL YEAR 2024 FINANCIAL RESULTS: Liquidity As of September 30, 2024 , the Company had $3.3 million in cash and cash equivalents. As of September 30, 2024 , the Company had 7,247,243 common shares outstanding, as adjusted for the 1-for-25 reverse stock split of the Company's common stock, effected on November 25, 2024 . During the year ended September 30, 2024 , the Company received net proceeds of $13.8 million from the issuance of equity. The Company expects to raise additional capital to support operations. Research and Development (R&D) Expenses R&D expenses were $11.9 million for the full year ended September 30, 2024 , compared to $14.8 million for the full year ended September 30, 2023 . The decrease in R&D expenses primarily reflects the completion of the Halo-Lido trial and completion of activities related to the regulatory resubmission for LYMPHIR, offset by shutdown costs associated with the end of the Phase 3 trial for Mino-Lok. We expect research and development expenses to decrease in fiscal year 2025 as we continue to focus on the commercialization of LYMPHIR through our majority-owned subsidiary, Citius Oncology and because we have completed the Phase 3 trial for Mino-Lok. General and Administrative (G&A) Expenses G&A expenses were $18.2 million for the full year ended September 30, 2024 , compared to $15.3 million for the full year ended September 30, 2023 . The increase was primarily due to costs associated with pre-launch and market research activities associated with LYMPHIR. General and administrative expenses consist primarily of compensation costs, professional fees for legal, regulatory, accounting and corporate development services, and investor relations expenses. Stock-based Compensation Expense For the full year ended September 30, 2024 , stock-based compensation expense was $11.8 million as compared to $6.6 million for the prior year. The increase of $5.2 million is largely due to the grant of options under the Citius Oncology stock plan. Stock-based compensation expense under the Citius Oncology stock plan was $7.5 million during the year ended September 30, 2024 , compared to $2.0 million for the year ended September 30, 2023 , as the plan was initiated in July 2023 . For the years ended September 30, 2024 and 2023, stock-based compensation expense also includes $47,547 and $130,382 , respectively, for the NoveCite stock option plan. In fiscal years 2023 and 2024, we granted options to our new employees and additional options to other employees, our directors, and consultants. Net loss Net loss was $39.4 million , or ($5.97) per share for the year ended September 30, 2024 , compared to a net loss of $32.5 million , or ($5.57) per share for the year ended September 30, 2023 , as adjusted for the reverse stock split. The increase in net loss reflects an increase in operating expense of $5.3 million offset by a decrease of $1.6 million in other income. Operating expense increased due to increases in stock-based compensation and general and administrative expenses, which were offset by decreased research and development expense. About Citius Pharmaceuticals, Inc. Citius Pharma is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products. In August 2024 , the FDA approved LYMPHIRTM, a targeted immunotherapy for an initial indication in the treatment of cutaneous T-cell lymphoma. Citius Pharma's late-stage pipeline also includes Mino-Lok®, an antibiotic lock solution to salvage catheters in patients with catheter-related bloodstream infections, and CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids. A Pivotal Phase 3 Trial for Mino-Lok and a Phase 2b trial for Halo-Lido were completed in 2023. Mino-Lok met primary and secondary endpoints of its Phase 3 Trial. Citius Pharma is actively engaged with the FDA to outline next steps for both programs. For more information, please visit www.citiuspharma.com . Forward-Looking Statements This press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements are made based on our expectations and beliefs concerning future events impacting Citius Pharma. You can identify these statements by the fact that they use words such as "will," "anticipate," "estimate," "expect," "plan," "should," and "may" and other words and terms of similar meaning or use of future dates. Forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated, and, unless noted otherwise, that apply to Citius Pharma are: our ability to raise additional money to fund our operations for at least the next 12 months as a going concern; our ability to commercialize LYMPHIR through our majority-owned subisity and any of our other product candidates that may be approved by the FDA; the estimated markets for our product candidates and the acceptance thereof by any market; the ability of our product candidates to impact the quality of life of our target patient populations; risks related to research using our assets but conducted by third parties; risks relating to the results of research and development activities, including those from our existing and any new pipeline assets; our ability to maintain compliance with Nasdaq's continued listing standards; our dependence on third-party suppliers; our ability to procure cGMP commercial-scale supply; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; uncertainties relating to preclinical and clinical testing; the early stage of products under development; market and other conditions; risks related to our growth strategy; patent and intellectual property matters; our ability to identify, acquire, close and integrate product candidates and companies successfully and on a timely basis; government regulation; competition; as well as other risks described in our Securities and Exchange Commission ("SEC") filings. These risks have been and may be further impacted by any future public health risks. Accordingly, these forward-looking statements do not constitute guarantees of future performance, and you are cautioned not to place undue reliance on these forward-looking statements. Risks regarding our business are described in detail in our SEC filings which are available on the SEC's website at www.sec.gov , including in Citius Pharma's Annual Report on Form 10-K for the year ended September 30, 2024 , filed with the SEC on December 27, 2024 , as updated by our subsequent filings with the SEC. These forward-looking statements speak only as of the date hereof, and we expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law. Investor Contact: Ilanit Allen ir@citiuspharma.com 908-967-6677 x113 Media Contact: STiR-communications Greg Salsburg Greg@STiR-communications.com -- Financial Tables Follow – CITIUS PHARMACEUTICALS, INC. CONSOLIDATED BALANCE SHEETS SEPTEMBER 30, 2024 AND 2023 2024 2023 ASSETS Current Assets: Cash and cash equivalents $ 3,251,880 $ 26,480,928 Inventory 8,268,766 — Prepaid expenses 2,700,000 7,889,506 Total Current Assets 14,220,646 34,370,434 Property and equipment, net — 1,432 Operating lease right-of-use asset, net 246,247 454,426 Other Assets: Deposits 38,062 38,062 In-process research and development 92,800,000 59,400,000 Goodwill 9,346,796 9,346,796 Total Other Assets 102,184,858 68,784,858 Total Assets $ 116,651,751 $ 103,611,150 LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities: Accounts payable $ 4,927,211 $ 2,927,334 License payable 28,400,000 — Accrued expenses 17,027 476,300 Accrued compensation 2,229,018 2,156,983 Operating lease liability 241,547 218,380 Total Current Liabilities 35,814,803 5,778,997 Deferred tax liability 6,713,800 6,137,800 Operating lease liability – non current 21,318 262,865 Total Liabilities 42,549,921 12,179,662 Commitments and Contingencies Stockholders' Equity: Preferred stock - $0.001 par value; 10,000,000 shares authorized; no shares issued and outstanding — — Common stock - $0.001 par value; 16,000,000 shares authorized; 7,247,243 and 6,354,371 shares issued and outstanding at September 30, 2024 and 2023, respectively 7,247 6,354 Additional paid-in capital 271,440,421 253,056,133 Accumulated deficit (201,370,218) (162,231,379) Total Citius Pharmaceuticals, Inc. Stockholders' Equity 70,077,450 90,831,108 Non-controlling interest 4,024,380 600,380 Total Equity 74,101,830 91,431,488 Total Liabilities and Equity $ 116,651,751 $ 103,611,150 Reflects a 1-for-25 reverse stock split effective November 25, 2024. CITIUS PHARMACEUTICALS, INC. CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE YEARS ENDED SEPTEMBER 30, 2024 AND 2023 2024 2023 Revenues $ — $ — Operating Expenses: Research and development 11,906,601 14,819,729 General and administrative 18,249,402 15,295,584 Stock-based compensation – general and administrative 11,839,678 6,616,705 Total Operating Expenses 41,995,681 36,732,018 Operating Loss (41,995,681) (36,732,018) Other Income: Interest income, net 758,000 1,179,417 Gain on sale of New Jersey net operating losses 2,387,842 3,585,689 Total Other Income Net 3,145,842 4,765,106 Loss before Income Taxes (38,849,839) (31,966,912) Income tax expense 576,000 576,000 Net Loss (39,425,839) (32,542,912) Net loss attributable to non-controlling interest 287,000 - Deemed dividend on warrant extension (1,047,312) (1,151,208) Net Loss Applicable to Common Stockholders $ (40,186,151) (33,694,120) Net Loss Per Share Applicable to Common Stockholders - Basic and Diluted $ (5.97) (5.57) Weighted Average Common Shares OutstandingNone
Pedro escaped punishment after swinging an arm at Bees substitute substitute Yehor Yarmoliuk without making contact. VAR reviewed the second-half incident but deemed there was no violent conduct. Frank and Brighton head coach Fabian Hurzeler disagreed about the decision. “As I understand the rules, you can’t swing your arm to try to hit someone,” said Frank. “If you hit them or not, it’s a red, that’s the way I understand the rules.” Frank spoke to the match officials, including referee Andy Madley, about the flashpoint at full-time. “They haven’t seen the situation yet, not on TV afterwards,” said Frank. “To be fair to him, I think the angle can be tricky so that’s why you’ve got VAR.” Asked about Frank’s assessment, Hurzeler replied: “Interesting opinion. I see it completely different. “For me, it’s not a red card. He tried to get free from a person.” Brighton were booed off after their winless run was stretched to six top-flight games. Albion dominated for large periods and hit the woodwork inside four minutes through Julio Enciso. Bees goalkeeper Mark Flekken made some important saves before being forced off injured in the 36th minute, albeit his replacement Hakon Valdimarsson was rarely tested on his Premier League debut. The Seagulls remain 10th ahead of Monday’s trip to Aston Villa, with Brentford a position and two points below moving towards their New Year’s Day showdown with Arsenal. Hurzeler thought the jeers at full-time were unfair. “The team doesn’t deserve that because in all the games we had in the last weeks they were all good, they were all intense, they were all where we thought we deserved more” said the German, whose team have lost to Fulham and Crystal Palace and drawn with Southampton, Leicester and West Ham in recent matches. “We try to work hard to satisfy our supporters, we try to give them what they deserve, we try to make them proud. “But the Premier League is tough. We know there will be (tough) periods we have to go through, especially with this young squad. “We try to stick together, find the positive and keep on going.” Brentford, who remain without a top-flight away win this term, had an early Yoane Wissa finish ruled out for offside following VAR intervention but barely threatened, despite an improved second-half showing. Frank, who is awaiting news on Flekken and defender Ben Mee, who also left the field injured, said: “I thought it was a fair point. “Brighton were better in the first half, no big, clearcut chances, and I thought we were better second half. “Overall, I’m happy with the performance, especially the way we defended. “We haven’t had too many clean sheets this season, so in that context I thought it was very impressive against a good Brighton team. “We know we have a lot of players out – we get two more injuries during the game. “The way the players showed their mentality and character and dug in was hugely impressive.”
Baltimore quarterback Lamar Jackson, the reigning NFL Most Valuable Player, leads fan balloting for the 2025 NFL Pro Bowl Games after one week of voting, the league announced on Monday. Ravens superstar Jackson set the overall pace with 44,681 votes followed by teammate Derrick Henry, the running back leader, in second overall at 40,729 votes. Philadelphia Eagles running back Saquon Barkley was third overall at 40,602, only 127 votes behind Henry in the rusher's race, with Buffalo quarterback Josh Allen fourth overall on 36,574 and Detroit running back Jahmyr Gibbs fifth on 35,637. The Detroit Lions lead all clubs in total votes received, followed by the Ravens, the two-time defending Super Bowl champion Kansas City Chiefs, the Minnesota Vikings and Pittsburgh Steelers. The NFL's revamped all-star event will be staged in Orlando, Florida, for the second consecutive year. In all, 88 players will gather on February 2 in skills competitions and a flag football showdown with coaches Peyton and Eli Manning. While other vote totals were not revealed, Washington rookie Jayden Daniels was the top NFC quarterback in the fan voting and top receivers were Minnesota's Justin Jefferson in the NFC and Cincinnati's Ja'Marr Chase in the AFC. NFL fans can vote as often as they wish through December 23 with selections decided by a consensus of ballots by players, coaches and fans with each group counting for one-third of every player's final total. NFL players and coaches will cast votes on December 27. js/rcw
NEW BRITAIN, Conn. — Elijah Howard ran for 110 yards and scored two touchdowns, the Central Connecticut defense made seven interceptions and the Blue Devils beat Duquesne, 21-14, on Saturday to claim the Northeast Conference’s automatic bid to the FCS playoffs. Howard provided the game-winning score by running it in from the 6, then threw the 2-point conversion to quarterback Brady Olson to cap the scoring with 13:44 left in the fourth quarter. The defense for the Blue Devils (7-5, 5-1) sealed the game when it stymied the Dukes (8-3, 5-1) on their final three possessions. Following Central Connecticut’s last touchdown, Jalen Howard sacked Darius Perrantes on Duquesne’s first play and forced a fumble that the Blue Devils recovered. Central Connecticut failed to add to the lead when Jack Barnum missed a 40-yard field, but Duquesne turned it back over when Perrantes threw an end zone pick. The Blue Devils punted after six plays, but, again, Duquesne saw another drive end with a Perrantes interception. Perrantes threw seven interceptions with three going to Christopher Jean, a pair to Davone Walden Jr. and one each to Deon McLean and Vincent Thomas. Duquesne secured at least a share of the NEC title for a conference record seventh time in program history with last week’s win over Wagner. It was the second straight year the Dukes played a winner-take-all game for the NEC automatic bid on the road in the final week of the regular season. Last year they beat Merrimack, 26-14, to win the NEC title outright.Victory Capital Management Inc. Sells 5,445 Shares of Qualys, Inc. (NASDAQ:QLYS)Ex-Queen’s Travail: Don’t let Good Deeds Become Regrettable, YCE Appeals to Govt
gremlin BlackBerry Overview Since mid-year 2024, BlackBerry Limited ( NYSE: BB ) shares traded in a narrow range of $2.15-$2.30. More recently, after November 22, 2024, BB stock broke out from $2.35 to trade at around $3.49 at the time of writing. The neglected Canadian firm, which has a Please [+] Follow me for coverage on deeply discounted stocks. To get more beyond these articles, get do-it-yourself tips and tricks in three ways: Subscribe to the Free DIY Tier to get a preview of the subscription. Read dozens of articles. This is completely separate from the alerts you get when following me. The Basic tier is the entry level, no-frills stock list. The Full Service is for readers who want access to five stock models, live online chat, and timely, actionable, stock alerts. Chris Lau is an individual investor and economist with 30 years of experience covering life science, technology, and dividend-growth income stocks. He has degrees in Microbiology and Economics. Chris runs the investing group DIY Value Investing where he shares his top stock picks of undervalued stocks with catalysts for upside, dividend-income recommendations with quant and payment calendar tracking, high upside plays, and research requests to help you become a better do-it-yourself investor. Learn more. Top Pick this year : this stock has become the best ever top pick . Highlighted is the one-day change, the editor's pick, and daily gain. The returns from the public articles are: 2023 Average Return: 8.4% 2022 Average Return: 6.9% 2021 Average Return 29.90% 2020 Average Return: 49.9% Flagship Products: 1. Top DIY Picks: Undervalued stocks have upcoming catalysts that markets do not expect. 2. Dividend-income Champs that have a long history of dividend growth. Includes printable calendar and quantitative scores. 3. DIY Risky Picks for a speculative allocation positive momentum for up to a moonshot, triple return. Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Stock market today: Wall Street slips as the 'Magnificent 7' weighs down the market NEW YORK (AP) — Stocks are closing lower as Wall Street ends a holiday-shortened week on a down note. The S&P 500 fell 1.1% Friday and the the Dow Jones Industrial Average lost 333 points, or 0.8%. The Nasdaq composite dropped 1.5%. Damian J. Troise, The Associated Press Dec 27, 2024 1:06 PM Share by Email Share on Facebook Share on X Share on LinkedIn Print Share via Text Message FILE - The New York Stock Exchange is shown behind the statue titled "Fearless Girl", Thursday, Dec. 12, 2024, in New York. (AP Photo/Julia Demaree Nikhinson, File) Listen to this article 00:04:36 NEW YORK (AP) — Stocks are closing lower as Wall Street ends a holiday-shortened week on a down note. The S&P 500 fell 1.1% Friday and the the Dow Jones Industrial Average lost 333 points, or 0.8%. The Nasdaq composite dropped 1.5%. The “Magnificent 7” stocks weighed on the market, led by declines in Nvidia, Tesla and Microsoft. Even with the loss, the S&P 500 had a modest gain for the week and is still headed for its second consecutive annual gain of more than 20%, the first time that has happened since 1997-1998. The yield on the 10-year Treasury rose to 4.62%. THIS IS A BREAKING NEWS UPDATE. AP’s earlier story follows below. NEW YORK (AP) — Technology stocks are dragging down the market Friday as Wall Street closes out a holiday-shortened week. The S&P 500 fell 1.3%, with more than 90% of stocks in the benchmark index losing ground. The benchmark index was managing to hold onto a modest gain for the week. The Dow Jones Industrial Average fell 418 points, or 1%, to 42,878 as of 1:43 p.m. Eastern time. The Nasdaq composite fell 1.8%. Technology stocks were the biggest weight on the market Friday. Semiconductor giant Nvidia slumped 2.7%. Its enormous valuation gives it an outsize influence on indexes. Other Big Tech stocks losing ground included Microsoft, with a 2% decline. A wide range of retailers also fell. Amazon fell 1.9% and Best Buy slipped 1.8%. The sector is being closely watched for clues on how it performed during the holiday shopping season. Energy stocks held up better than the rest of the market, with a loss of just 0.1% as crude oil prices rose 1.4%. The S&P 500 gained nearly 3% over a 3-day stretch before breaking for the Christmas holiday. On Thursday, the index posted a small decline. “There's just some uncertainty over this relief rally we've witnessed since last week,” said Adam Turnquist, chief technical strategist for LPL Financial. Despite Friday's drop, the market is moving closer to another standout annual finish . The S&P 500 is on track for a gain of around 25% in 2024. That would mark a second consecutive yearly gain of more than 20%, the first time that has happened since 1997-1998. The gains have been driven partly by upbeat economic data showing that consumers continued spending and the labor market remained strong. Inflation, while still high, has also been steadily easing. A report on Friday showed that sales and inventory estimates for the wholesales trade industry fell 0.2% in November, following a slight gain in October. That weaker-than-expected report follows an update on the labor market Thursday that showed unemployment benefits held steady last week. The stream of upbeat economic data and easing inflation helped prompt a reversal in the Federal Reserve's interest rate policy this year. Expectations for interest rate cuts also helped drive market gains. The central bank recently delivered its third cut to interest rates in 2024. Even though Inflation has come closer to the central bank's target of 2%, it remains stubbornly above that mark and worries about it heating up again have tempered the forecast for more interest rate cuts. Inflation concerns have added to uncertainties heading into 2025, which include the labor market’s path ahead and shifting economic policies under incoming President Donald Trump. Worries have risen that Trump’s preference for tariffs and other policies could lead to higher inflation , a bigger U.S. government debt and difficulties for global trade. Amedisys rose 4.7% after the home health care and hospice services provider agreed to extend the deadline for its sale to UnitedHealth Group. The Justice Department had sued to block the $3.3 billion deal, citing concerns he combination would hinder access to home health and hospice services in the U.S. The move to extend the deadline comes ahead of an expected shift in regulatory policy under Trump. The incoming administration is expected to have a more permissive approach to dealmaking and is less likely to raise antitrust concerns. In Asia, Japan’s benchmark index surged as the yen remained weak against the dollar. Stocks in South Korea fell after the main opposition party voted to impeach the country’s acting leader. Markets in Europe gained ground. Bond yields held relatively steady. The yield on the 10-year Treasury rose to 4.61% from 4.59% late Thursday. The yield on the two-year Treasury slipped to 4.31% from 4.33% late Thursday. Wall Street will have more economic updates to look forward to next week, including reports on pending home sales and home prices. There will also be reports on U.S. construction spending and snapshots of manufacturing activity. Damian J. Troise, The Associated Press See a typo/mistake? Have a story/tip? This has been shared 0 times 0 Shares Share by Email Share on Facebook Share on X Share on LinkedIn Print Share via Text Message More National Business S&P/TSX composite, U.S. markets end the trading day lower Friday Dec 27, 2024 1:24 PM B.C. court orders fraudster who owes $36.7M to pay from retirement funds Dec 27, 2024 11:54 AM Tugboats, crews try to refloat ship stuck in St. Lawrence River near Montreal Dec 27, 2024 9:40 AM Featured FlyerUS President-elect Donald Trump filed a brief Friday urging the Supreme Court to pause a law that would ban TikTok the day before his January 20 inauguration if it is not sold by its Chinese owner ByteDance. “In light of the novelty and difficulty of this case, the court should consider staying the statutory deadline to grant more breathing space to address these issues,” Trump’s legal team wrote, to give him “the opportunity to pursue a political resolution.” Trump was fiercely opposed to TikTok during his 2017-21 first term, and tried in vain to ban the video app on national security grounds. The Republican voiced concerns — echoed by political rivals — that the Chinese government might tap into US TikTok users’ data or manipulate what they see on the platform. US officials had also voiced alarm over the popularity of the video-sharing app with young people, alleging that its parent company is subservient to Beijing and that the app is used to spread propaganda, claims denied by the company and the Chinese government. Trump called for a US company to buy TikTok, with the government sharing in the sale price, and his successor Joe Biden went one stage further — signing a law to ban the app for the same reasons. Trump has now, however, reversed course. “Now (that) I’m thinking about it, I’m for TikTok, because you need competition,” he recently told Bloomberg. “If you don’t have TikTok, you have Facebook and Instagram — and that’s, you know, that’s Zuckerberg.” Facebook, founded by Mark Zuckerberg and part of his Meta tech empire, was among the social media networks that banned Trump after attacks by his supporters on the US Capitol on January 6, 2021. The ban was driven by concerns that he would use the platform to promote more violence. Those bans on major social media platforms were later lifted. In the brief filed on Friday, Trump’s lawyer made it clear the president-elect did not take a position on the legal merits of the current case. “President Trump takes no position on the underlying merits of this dispute,” John Sauer wrote in the amicus curiae — or “friend of the court” — brief. “Instead, he respectfully requests that the court consider staying the act’s deadline for divestment of January 19, 2025, while it considers the merits of this case, thus permitting President Trump’s incoming Administration the opportunity to pursue a political resolution of the questions at issue in the case.” With 2,400 staff representing 100 different nationalities, AFP covers the world as a leading global news agency. AFP provides fast, comprehensive and verified coverage of the issues affecting our daily lives.
Buying Advice: In search of health and happiness using the science of ergonomicsWhile holiday spending may have filled merchants’ coffers, the challenge will be to keep consumer momentum going at the registers, particularly at brick-and-mortar stores. The PYMNTS Intelligence report “ 2024 Global Digital Shopping Index: U.S. Edition ,” created in collaboration with Visa Acceptance Solutions , found that about a third of United States consumers are Click-and-MortarTM shoppers, choosing experiences that work convenient digital features into the in-store shopping journey. Drilling down a bit , the study found that 19% of U.S. consumers prefer to shop in stores with the assistance of digital technologies, and 11% prefer to make purchases online for in-store pickup. Three-quarters of shoppers want to be able to use their preferred payment methods in the store. In further illustration of the appeal of the tactile commerce experience, Visa said this week that amid 4.8% growth in overall holiday shopping , 77% of holiday payment volume happened at brick-and-mortar establishments “versus 23% online, showing the in-store experience remains important for the consumer.” In-store spending was up 4.1% compared to last year, accelerating from 2023 year-over-year gains of 1.6%. Paying Over Time At the same time, the accumulation of card debt (the average balance is north of $5,000) means that consumers are finding it useful , and perhaps even necessary, to stagger payments over time. Card-linked offers, in addition, likely can keep consumers aware of, and incentivized by, the opportunity to earn rewards, discounts and cash back. The PYMNTS Intelligence report “ Maximizing Holiday Value: The Strategic Value of Early Pay Later Visibility ” found that the availability of pay-later options plays an important role in where consumers decide to shop. According to the report, 43% of consumers said that whether their preferred financing option is available strongly influences their choice of retailer. Among users of general-purpose credit card-linked installment plans, 35% reported using these plans more frequently over the past year. Moving the financing options and the digital presentation of offers earlier into the buying process can help boost merchants’ sales conversions. Consider the fact that two-thirds of card users shop with brands or merchants where they are members of loyalty or rewards programs. However, 38% of consumers are not familiar with rewards programs, which means that additional outreach on the part of the retailers (and the issuers, using receipt-level data) can help move the needle on using those offers in-store to make the sale. Installments and Card-Linked Offers in the Aisles The data underscored the rewards that accrue for merchants who surface card-linked pay-later plans at the right time, in the right way. The PYMNTS Intelligence report “ Merchants’ Evolving Perspective on the Value of Card-Linked Pay Later Plans ” found that consumers spend more than twice as much on retail items when using general-purpose card-linked installment plans than what we might term “pure play” buy now, pay later (BNPL) options. Median transaction amounts on card-linked plans reached $1,500, and 72% of merchants prefer customers to finance installments with general-purpose credit cards. The share of merchants that offer general-purpose credit card-linked installment plans has increased by 16% since December of last year. With some granularity on the appeal in the brick-and-mortar channel, for in-store transactions, merchants said consumers’ use of general-purpose credit card-linked installment plans is growing more than their use of BNPL. Eighty-two percent of merchants reported growth in consumers’ use of card-based installment options during in-store checkout through 2024.
Inflation-fighting tips for retirees to consider
The Maharashtra Prisons and Correctional Services Act, 2024, is based on the Model Prisons Bill, 2023, sent by the Centre to the states, Chief Minister Devendra Fadnavis told the House. Nagpur: The Maharashtra legislative assembly here on Friday passed a bill seeking to reform the prison system in the state. The Maharashtra Prisons and Correctional Services Act, 2024, is based on the Model Prisons Bill, 2023, sent by the Centre to the states, Chief Minister Devendra Fadnavis told the House. A high-security prison and detention centre will be set up in Mumbai, while a new prison being built in Pune will be a two-storey facility, he added. A plot of land has been finalised for the new prison in Mumbai, the CM said. As many as 1,600 accused who have got bail continue to stay in prison in the state for the lack of money to pay for bail bond, he informed. The bill provides for categories of prisons such as special prison, open prison for women, temporary prison and open colony. Open prisons and open colonies will help with rehabilitation and reintegration of former jail inmates after their release, Fadnavis said. The bill also provides for the constitution of a `prison and correctional prison force’. A welfare fund for prison staff and another fund for the welfare of prisoners is also an important feature of the legislation, the CM said. It also provides for better segregation of various categories of prisoners and their special needs as women, transgenders, under-trial prisoners, convicts, high-risk prisoners and habitual offenders. The bill also makes provisions for a grievance-redressal mechanism for prisoners, after-care rehabilitation service, and a separate women’s ward in prison hospitals. An undertrial review committee will be set up in every district for periodical review of all undertrial prisoners and to take measures for speedy disposal of cases and make appropriate recommendations to trial courts. Technology including biometrics, closed-circuit television (CCTV), scanning and detection services, Radio Frequency Identification and video conference facilities will be used for effective management and supritendence of prisons and to ensure the safety of inmates, the CM said. The entire prison administration will be computerized, the chief minister said. Congress MLA Nana Patole and Sanjay Kute (BJP) said prison reforms should not lead to a situation where criminals would like to remain in jail. There should be no lavishness, they said. Fadnavis assured that there would be no “five-star facility”, adding that the reforms aim to protect human rights of jail inmates. Kute said social health will be affected if criminals get lavish treatment in jail. Aaditya Thackeray (Shiv Sena UBT) said artificial intelligence should be used to create digital footprint of prisoners so that care can be taken after a prisoner walks out of the jail. Fadnavis said the use of AI for this purpose will take time. Sana Malik (NCP) said the right to health is part of the right to life. Mumbai’s Arthur Road Jail has the capacity to accommodate 804 inmates but some 3,000 prisoners are lodged there, she claimed. Fadnavis conceded that the number of doctors available is small in view of the number of prison inmates. “We will focus on reducing the number of undertrials,” the chief minister said. Click for more latest India news . Also get top headlines and latest news from India and around the world at News9.The military's tradition of tracking Santa Claus on his gravity-defying sweep across the globe will carry on this Christmas Eve, even if the U.S. government shuts down , officials said Friday. Each year, at least 100,000 kids call into the North American Aerospace Defense Command to inquire about Santa’s location. Millions more follow online — in nine languages — as St. Nick swoops along the earth's meridians. “We fully expect for Santa to take flight on Dec. 24 and NORAD will track him," the U.S.-Canadian agency said in a statement. On any other night, NORAD is scanning the heavens for potential threats , such as last year's Chinese spy balloon . But on Christmas Eve, volunteers in Colorado Springs, Colorado, are fielding questions like, “When is Santa coming to my house?” and, “Am I on the naughty or nice list?” The endeavor is supported by local and corporate sponsors, who also help shield the tradition from Washington dysfunction. Bob Sommers, 63, a civilian contractor and NORAD volunteer, told The Associated Press that there are "screams and giggles and laughter” when families call in, usually on speakerphone. Sommers often says on the call that everyone must be asleep before Santa arrives, prompting parents to say, "Do you hear what he said? We got to go to bed early." NORAD's annual tracking of Santa has endured since the Cold War , predating ugly sweater parties and Mariah Carey classics . Here's how it began and why the phones keep ringing. The origin story is Hollywood-esque It started with a child's accidental phone call in 1955. The Colorado Springs newspaper printed a Sears advertisement that encouraged children to call Santa, listing a phone number. A boy called. But he reached the Continental Air Defense Command, now NORAD, a joint U.S. and Canadian effort to spot potential enemy attacks. Tensions were growing with the Soviet Union, along with anxieties about nuclear war. Air Force Col. Harry W. Shoup picked up an emergency-only “red phone” and was greeted by a tiny voice that began to recite a Christmas wish list. “He went on a little bit, and he takes a breath, then says, ‘Hey, you’re not Santa,’” Shoup told The Associated Press in 1999. Realizing an explanation would be lost on the youngster, Shoup summoned a deep, jolly voice and replied, “Ho, ho, ho! Yes, I am Santa Claus. Have you been a good boy?” Shoup said he learned from the boy's mother that Sears mistakenly printed the top-secret number. He hung up, but the phone soon rang again with a young girl reciting her Christmas list. Fifty calls a day followed, he said. In the pre-digital age, the agency used a 60-by-80-foot (18-by-24-meter) plexiglass map of North America to track unidentified objects. A staff member jokingly drew Santa and his sleigh over the North Pole. The tradition was born. “Note to the kiddies,” began an AP story from Colorado Springs on Dec. 23, 1955. “Santa Claus Friday was assured safe passage into the United States by the Continental Air Defense Command.” In a likely reference to the Soviets, the article noted that Santa was guarded against possible attack from "those who do not believe in Christmas.” Is the origin story humbug? Some grinchy journalists have nitpicked Shoup's story, questioning whether a misprint or a misdial prompted the boy's call. In 2014, tech news site Gizmodo cited an International News Service story from Dec. 1, 1955, about a child's call to Shoup. Published in the Pasadena Independent, the article said the child reversed two digits in the Sears number. "When a childish voice asked COC commander Col. Harry Shoup, if there was a Santa Claus at the North Pole, he answered much more roughly than he should — considering the season: ‘There may be a guy called Santa Claus at the North Pole, but he’s not the one I worry about coming from that direction,'" Shoup said in the brief piece. In 2015, The Atlantic magazine doubted the flood of calls to the secret line, while noting that Shoup had a flair for public relations. Phone calls aside, Shoup was indeed media savvy. In 1986, he told the Scripps Howard News Service that he recognized an opportunity when a staff member drew Santa on the glass map in 1955. A lieutenant colonel promised to have it erased. But Shoup said, “You leave it right there,” and summoned public affairs. Shoup wanted to boost morale for the troops and public alike. “Why, it made the military look good — like we’re not all a bunch of snobs who don’t care about Santa Claus,” he said. Shoup died in 2009. His children told the StoryCorps podcast in 2014 that it was a misprinted Sears ad that prompted the phone calls. “And later in life he got letters from all over the world,” said Terri Van Keuren, a daughter. "People saying ‘Thank you, Colonel, for having, you know, this sense of humor.’” A rare addition to Santa's story NORAD's tradition is one of the few modern additions to the centuries-old Santa story that have endured, according to Gerry Bowler, a Canadian historian who spoke to the AP in 2010. Ad campaigns or movies try to “kidnap” Santa for commercial purposes, said Bowler, who wrote “Santa Claus: A Biography.” NORAD, by contrast, takes an essential element of Santa's story and views it through a technological lens. In a recent interview with the AP, Air Force Lt. Gen. Case Cunningham explained that NORAD radars in Alaska and Canada — known as the northern warning system — are the first to detect Santa. He leaves the North Pole and typically heads for the international dateline in the Pacific Ocean. From there he moves west, following the night. “That's when the satellite systems we use to track and identify targets of interest every single day start to kick in,” Cunningham said. “A probably little-known fact is that Rudolph’s nose that glows red emanates a lot of heat. And so those satellites track (Santa) through that heat source.” NORAD has an app and website, www.noradsanta.org , that will track Santa on Christmas Eve from 4 a.m. to midnight, mountain standard time. People can call 1-877-HI-NORAD to ask live operators about Santa’s location from 6 a.m. to midnight, mountain time. Ben Finley, The Associated PressBaltimore quarterback Lamar Jackson, the reigning NFL Most Valuable Player, leads fan balloting for the 2025 NFL Pro Bowl Games after one week of voting, the league announced on Monday. Ravens superstar Jackson set the overall pace with 44,681 votes followed by teammate Derrick Henry, the running back leader, in second overall at 40,729 votes. Philadelphia Eagles running back Saquon Barkley was third overall at 40,602, only 127 votes behind Henry in the rusher's race, with Buffalo quarterback Josh Allen fourth overall on 36,574 and Detroit running back Jahmyr Gibbs fifth on 35,637. The Detroit Lions lead all clubs in total votes received, followed by the Ravens, the two-time defending Super Bowl champion Kansas City Chiefs, the Minnesota Vikings and Pittsburgh Steelers. The NFL's revamped all-star event will be staged in Orlando, Florida, for the second consecutive year. In all, 88 players will gather on February 2 in skills competitions and a flag football showdown with coaches Peyton and Eli Manning. While other vote totals were not revealed, Washington rookie Jayden Daniels was the top NFC quarterback in the fan voting and top receivers were Minnesota's Justin Jefferson in the NFC and Cincinnati's Ja'Marr Chase in the AFC. NFL fans can vote as often as they wish through December 23 with selections decided by a consensus of ballots by players, coaches and fans with each group counting for one-third of every player's final total. NFL players and coaches will cast votes on December 27. js/rcw
Pedro escaped punishment after swinging an arm at Bees substitute substitute Yehor Yarmoliuk without making contact. VAR reviewed the second-half incident but deemed there was no violent conduct. Frank and Brighton head coach Fabian Hurzeler disagreed about the decision. “As I understand the rules, you can’t swing your arm to try to hit someone,” said Frank. “If you hit them or not, it’s a red, that’s the way I understand the rules.” Frank spoke to the match officials, including referee Andy Madley, about the flashpoint at full-time. “They haven’t seen the situation yet, not on TV afterwards,” said Frank. “To be fair to him, I think the angle can be tricky so that’s why you’ve got VAR.” Asked about Frank’s assessment, Hurzeler replied: “Interesting opinion. I see it completely different. “For me, it’s not a red card. He tried to get free from a person.” Brighton were booed off after their winless run was stretched to six top-flight games. Albion dominated for large periods and hit the woodwork inside four minutes through Julio Enciso. Bees goalkeeper Mark Flekken made some important saves before being forced off injured in the 36th minute, albeit his replacement Hakon Valdimarsson was rarely tested on his Premier League debut. The Seagulls remain 10th ahead of Monday’s trip to Aston Villa, with Brentford a position and two points below moving towards their New Year’s Day showdown with Arsenal. Hurzeler thought the jeers at full-time were unfair. “The team doesn’t deserve that because in all the games we had in the last weeks they were all good, they were all intense, they were all where we thought we deserved more” said the German, whose team have lost to Fulham and Crystal Palace and drawn with Southampton, Leicester and West Ham in recent matches. “We try to work hard to satisfy our supporters, we try to give them what they deserve, we try to make them proud. “But the Premier League is tough. We know there will be (tough) periods we have to go through, especially with this young squad. “We try to stick together, find the positive and keep on going.” Brentford, who remain without a top-flight away win this term, had an early Yoane Wissa finish ruled out for offside following VAR intervention but barely threatened, despite an improved second-half showing. Frank, who is awaiting news on Flekken and defender Ben Mee, who also left the field injured, said: “I thought it was a fair point. “Brighton were better in the first half, no big, clearcut chances, and I thought we were better second half. “Overall, I’m happy with the performance, especially the way we defended. “We haven’t had too many clean sheets this season, so in that context I thought it was very impressive against a good Brighton team. “We know we have a lot of players out – we get two more injuries during the game. “The way the players showed their mentality and character and dug in was hugely impressive.”
50 best Amazon Cyber Monday and Black Friday deals live on coffee machines, Ring doorbells and Kindles
- Previous: jili super ace demo mode
- Next: jili super ace free game
